Neurovalens

Neurovalens is a health-tech company based in Belfast, Northern Ireland, focused on developing non-invasive neurostimulation medical devices. Founded in 2015 by Dr. Jason McKeown, the company aims to address health challenges such as chronic insomnia and anxiety through innovative technology. Their devices stimulate deep brain regions without surgical implantation, using electrical pulses to influence areas of the brain that regulate sleep and emotional states. The company's flagship products include Modius Sleep, designed to improve sleep quality for patients with chronic insomnia, and Modius Calm, which targets anxiety. Both devices have received FDA 510(k) clearances and utilize vestibular nerve stimulation through self-adhesive electrode pads placed behind the ears. Neurovalens is also conducting clinical trials for additional products aimed at treating conditions like PTSD, diabetes, and weight management, expanding their range of neurostimulation applications. The company is committed to integrating its products into healthcare systems to provide non-pharmaceutical treatment options for patients.

• Employees 25
• Founded 2013
• Annual Revenue $9775000
• Total Funding $35062338